Physical characteristics and chemical degradation of amorphous quinapril hydrochloride

Journal of Pharmaceutical Sciences

Volumn 89, Issue 1, 2000, Pages 128-143

  Guo, Yushen ^a,c   Byrn, Stephen R ^b   Zografi, George ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b PURDUE UNIVERSITY   (United States)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

QUINAPRIL;

ARTICLE; CHEMICAL REACTION KINETICS; DRUG DEGRADATION; DRUG STABILITY; SURFACE PROPERTY; THERMOGRAVIMETRY;

EID: 0033971208     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6017(200001)89:1<128::AID-JPS13>3.0.CO;2-Z     Document Type: Article

References (46)

1. Paul IC, Curtin DY. 1973. Thermal induced organic reactions in the solid state. Acc Chem Res 6:217-225.
2. Byrn SR. 1982. Solid state chemistry of drugs, 1st ed. New York: Academic.
3. Pikal MJ, Lukes AL, Lang, JE, Gaines K. 1978. Quantitative crystallinity determinations for beta-lactam antibiotics by solution calorimetry: correlations with stability. J Pharm Sci 67:767-773.
4. Oberholtzer ER, Brenner GS. 1979. Cefoxitine sodium: solution and solid-state chemical studies. J Pharm Sci 68:863-866.
5. Oguchi T, Yonemochi E, Yamamoto K, Nakai Y. 1989. Freeze-drying of drug additive binary-systems. 2. Relationship between decarboxylation behavior and molecular states of P-aminosalicylic acid. Chem Pharm Bull 37:3088-3091.
6. Hancock BC, Zografi G. 1997. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 86:1-12.
7. Xu W. August 1997. Investigations of solid-state stability of selected bioactive compounds. Ph.D. Thesis. West Lafayette, IN: Purdue University.
8. Gu L, Strickley RG. 1987. Diketopiperazine formation, hydrolysis, and epimerization of the new dipeptide angiotensin-converting enzyme inhibitor RS-10085. Pharm Res 4:392-397.
9. Cotton ML, Wu DW, Vadas EB. 1987. Drug-excipient interaction study of enalapril maleate using thermal analysis and scanning electron microscopy. Int J Pharm 40:129-142.
10. Steinberg SM, Bada JL. 1983. Peptide decomposition in the neutral pH region via the formation of diketopiperazines. J Org Chem 48:2295-2298.
11. Goolcharran C, Borchardt RT. 1998. Kinetics of diketopiperazine formation using model peptides. J Pharm Sci 87:283-288.
12. Kertscher U, Bienert M, Krause E, Sepetov NF, Mehlis B. 1993. Spontaneous chemical degradation of substance P in the solid phase and in solution. Int J Pept Protein Res 41:207-221.
13. Battersby JE, Hancock WS, Canova-Davis E, Oeswein J, O'Connor B. 1994. Diketopiperazine formation and N-terminal degradation in recombinant human growth hormone. Int J Pept Protein Res 44:215-222.
14. Gisin BF, Merrifield RB. 1972. Carboxyl-catalyzed intramolecular aminolysis. A side reaction on solid-phase peptide synthesis. J Am Chem Soc 94: 3102-3106.
15. Goel OP, Krolls J. U. S. Patent 4,761,476, August 2, 1988.
16. Klutchko S, Blankley CJ, Fleming RW, Hinkley JM, Werner AE, Nordin I, Holmes A, Hoefle ML, Cohen DM, Essenburg AD, Kaplan HR. 1986. Synthesis of novel angiotensin converting enzyme inhibitor quinapril and related compounds. A divergence of structure-activity relationships for non-sulfhydryl and sulfhydryl types. J Med Chem 29: 1953-1961.
17. Yang YW. August 1985. Capillary flow phenomena as related to wettability in porous media. Ph.D. Thesis. Madison, WI: University of Wisconsin-Madison.
18. Saleki-Gerhardt A, Zografi G. 1994. Non-isothermal and isothermal crystallization of sucrose from the amorphous state. Pharm Res 11:1166-1173.
19. Hausin RJ, Codding PW. 1991. Molecular and crystal structures of MDL27,467A hydrochloride and quinapril hydrochloride, two ester derivatives of potent angiotensin converting enzyme inhibitors. J Med Chem 34:511-517.
20. DeBolt M, Esteal A, Macedo P, Moynihan C. 1976. Analysis of structural relaxation in glass using rate heating data. J Am Ceram Soc 59:16-21.
21. Andronis V, Zografi G. 1998. The molecular mobility of supercooled amorphous indomethacin as a function of temperature and relative humidity. Pharm Res. 15:835-841.
22. Mutha SC, Ludemann WB. 1976. Solid-state anomalies in IR spectra of compounds of pharmaceutical interest. J Pharm Sci 65:1400-1403.
23. Nakanishi K, Solomon PH. 1977. Infrared absorption spectroscopy, 2nd ed. San Francisco, CA: Holden-Day.
24. Leung SS, Grant JW. 1997. Solid state stability studies of model dipeptides: aspartame and aspartylphenylalanine. J Pharm Sci 12:305-308.
25. Straub JA, Akiyama A, Parmar P, Musso GF. 1995. Chemical pathways of degradation of bradykinin analog, RMP-7. Pharm Res 12:305-308.
26. Moynihan CT, Easteal AJ, Wilder J, Tucker J. 1974. Dependence of glass transition temperature on heating and cooling rate. J Phys Chem 78: 2673-2677.
27. Andronis V, Zografi G. 1997. Molecular mobility of supercooled amorphous indomethacin; determined by dynamic mechanical analysis. Pharm Res. 14: 410-414.
28. Bohmer R, Ngai KL, Angell CA, Plazek DJ. 1993. Nonexponential relations in strong and fragile glass formers. J Chem Phys 99:4201-4209.
29. Hodge IM. 1994. Enthalpy relaxation and recovery in amorphous materials. J Non-Cryst Solids 169: 211-266.
30. Hodge IM. 1995. Physical aging in polymer glasses. Science 267:1945-1947.
31. Scherer GW. 1990. Theories of relaxation. J Non-Cryst Solids 123:75-89.
32. Angell CA. 1995. Formation of glasses from liquids and biopolymers. Science 267:1924-1935.
33. Rice SA. 1985. Comprehensive chemical kinetics. In: Bamford CH, Tipper CFH, Campton RG, editors. Diffusion-limited reactions. Vol 25. Amsterdam: Elsevier.
34. Fujara F, Geil B, Sillescu H, Fleischer G. 1992. Translational and rotational diffusion in super-cooled orthoterphenyl close to the glass transition. Z Phys B: Condensed Matter 88:195-204.
35. Home RA, Axelrod EH. 1964. Proton mobility and electron exchange in aqueous media. J Chem Phys 40:1518-1522.
36. Moore JAW, Jorgenson JW. 1995. Resolution of cis and trans isomers of peptides containing proline using capillary zone electrophoresis. Anal Chem 67:3464-3475.
37. Eberhardt ES, Loh SN, Hinck AP, Raines RT. 1992. Solvent effects on the energetics of prolyl peptide bond isomerization. J Am Chem Soc 114: 5437-5439.
38. 13C NMR thermal equilibration. Biopolymers 16:937-944.
39. Cheng HN, Bovey FA. 1977. Cis-trans equilibrium and kinetic studies of acetyl-L-proline and glycyl-L-proline. Biopolymers 16:1465-1472.
40. Fischer S, Dunbrack JRL, Karplus M. 1994. Cis-trans imide isomerization of the proline dipeptide. J Am Chem Soc 116:11931-11937.
41. Brandts, JF, Halvorson HR, Brennan M. 1975. Consideration of the possibility that the slow step in protein denaturation reactions is due to cis-trans isomerism of proline residues. Biochem 14: 4953-4963.
42. Camiller P, Ellul R, Kirby A, Mujahid TG. 1979. The spontaneous formation of amides. The mechanism of lactam formation from 3-(2-amino-phenyl)propionic acid. J Chem Soc Perkin Trans II 1617-1620.
43. Strickley RG, Visor GC, Lin L, Gu L. 1989. An unexpected pH effect on the stability of moexipril lyophilized powder. Pharm Res 6:971-975.
44. Blazejowdki J. 1983. Thermal properties of amine hydrochlorides. Part I. Thermolysis of primary N-alkylammonium chlorides. Thermochimica Acta 68:233-260.
45. Lowry TH, Richardson KS. 1981. Mechanism and theory in organic chemistry, 2nd ed. New York: Harper & Row.
46. Sharp JH, Wentworth SA. 1969. Kinetic analysis of thermogravimetric data. Anal Chem 41:2060-2062.